4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026379
Options or other derivatives
- Chief Strategy Officer acquired 506,276 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Randall Charles Hiram Chief Strategy Officer | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +116,321 | 116,321 | D: show line 1 in the form | |||||
| Randall Charles Hiram Chief Strategy Officer | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +116,321 | 116,321 | D: show line 2 in the form | |||||
| Randall Charles Hiram Chief Strategy Officer | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +116,321 | 116,321 | D: show line 3 in the form | |||||
| Randall Charles Hiram Chief Strategy Officer | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +11,632 | 11,632 | D: show line 4 in the form | |||||
| Randall Charles Hiram Chief Strategy Officer | 2021-10-22 | Grant or award · Earnout Rights (Restricted Stock Units) | +145,681 | 145,681 | D: show line 5 in the form |
Loading xslF345X03/ownership.xml…